4basebio (LON:4BB) Shares Up 1.2% – Still a Buy?

4basebio PLC (LON:4BB) shares were up 1.2% during trading on Tuesday . The stock traded as high as GBX 850 ($11.60) and last traded at GBX 850 ($11.60). Approximately 472 shares traded hands during trading, a decline of 60% from the average daily volume of 1,181 shares. The stock had previously closed at GBX 840 ($11.47).

4basebio Trading Up 1.2%

The firm has a market capitalization of £131.62 million, a price-to-earnings ratio of -904.26 and a beta of 1.09. The company has a debt-to-equity ratio of 201.47, a current ratio of 2.73 and a quick ratio of 3.52. The firm’s 50-day simple moving average is GBX 925.18 and its 200 day simple moving average is GBX 1,038.88.

About 4basebio

4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients.

Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients.